Product Information

LEVOTHYROXINE 300 MCG TABLET is a generic product labeled by Lannett Company Inc., priced at $0.0999 per EA under NDC 00527329146. Its NADAC has been published 314 times since Aug 19, 2020.

FDA first approved this application on Mar 1, 2002. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVOTHYROXINE 300 MCG TABLET

Levothyroxine Sodium
$0.0999per EA

Strength

300 ug/1

NDC

00527329146

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021342

FDA Approved

3/1/2002

TE Code

AB1,AB2,AB3

On Market Since

8/3/2020

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for LEVOTHYROXINE 300 MCG TABLET has been published 314 times since Aug 19, 2020, and over the history we have for it it has declined 80.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0999 per EA
All-time high$0.6020 (Feb 10, 2021)
All-time low$0.0715 (Jul 17, 2024)
52-week high$0.1278
52-week low$0.0999
Median price$0.1439
Average price$0.2210
Largest weekly change+78.9% (Aug 21, 2024)
Weeks tracked314
Tracking sinceAug 19, 2020

Price History

1W

-6.4%

1M

-7.9%

3M

-11.3%

6M

-13.6%

1Y

-21.9%

3Y

-37.3%

5Y

-79.5%

All

-80.7%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LEVOTHYROXINE 300 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 300 MCG TABLET, manufactured by Lannett Company Inc., is $0.0999 per EA (NDC 00527329146), effective Aug 19, 2026.

How has the price of LEVOTHYROXINE 300 MCG TABLET changed over time?

Over the history we have for it, the NADAC for LEVOTHYROXINE 300 MCG TABLET has declined 80.7%. It has been tracked across 314 weekly CMS publications since Aug 19, 2020.

What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 300 MCG TABLET?

Since Aug 19, 2020, the NADAC for LEVOTHYROXINE 300 MCG TABLET has ranged from a low of $0.0715 (Jul 17, 2024) to a high of $0.6020 (Feb 10, 2021), with a median of $0.1439 per EA.

Are there cheaper alternatives to LEVOTHYROXINE 300 MCG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 300 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LEVOTHYROXINE 300 MCG TABLET?

LEVOTHYROXINE 300 MCG TABLET (NDC 00527329146) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.